Albert Labs is a clinical research and drug development company addressing mental health care needs. Through a succinct clinical pathway, Albert Labs look to develop & commercialize its novel therapeutic treatments and, in doing so, deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access while developing licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs' development program, is thought to affect over 16 million patients worldwide.